vs
Side-by-side financial comparison of INTERGROUP CORP (INTG) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $17.3M, roughly 1.6× INTERGROUP CORP). INTERGROUP CORP runs the higher net margin — 8.8% vs -147.1%, a 155.9% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs -67.6%).
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
INTG vs SPRY — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $28.1M |
| Net Profit | $1.5M | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | 11.6% | -147.6% |
| Net Margin | 8.8% | -147.1% |
| Revenue YoY | 19.8% | -67.6% |
| Net Profit YoY | 155.6% | -182.8% |
| EPS (diluted) | $0.71 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.3M | $28.1M | ||
| Q3 25 | $17.9M | $32.5M | ||
| Q2 25 | $16.2M | $15.7M | ||
| Q1 25 | $16.8M | $8.0M | ||
| Q4 24 | $14.4M | $86.6M | ||
| Q3 24 | $16.9M | $2.1M | ||
| Q2 24 | $13.4M | $500.0K | ||
| Q1 24 | $14.9M | $0 |
| Q4 25 | $1.5M | $-41.3M | ||
| Q3 25 | $-535.0K | $-51.2M | ||
| Q2 25 | $-2.2M | $-44.9M | ||
| Q1 25 | $-578.0K | $-33.9M | ||
| Q4 24 | $-2.7M | $49.9M | ||
| Q3 24 | $-398.0K | $-19.1M | ||
| Q2 24 | $-4.9M | $-12.5M | ||
| Q1 24 | $-3.2M | $-10.3M |
| Q4 25 | 11.6% | -147.6% | ||
| Q3 25 | 15.3% | -163.7% | ||
| Q2 25 | 8.1% | -302.9% | ||
| Q1 25 | 14.0% | -466.3% | ||
| Q4 24 | 5.9% | 54.5% | ||
| Q3 24 | 18.5% | -1051.6% | ||
| Q2 24 | 3.7% | -3068.0% | ||
| Q1 24 | 4.8% | — |
| Q4 25 | 8.8% | -147.1% | ||
| Q3 25 | -3.0% | -157.4% | ||
| Q2 25 | -13.9% | -285.6% | ||
| Q1 25 | -3.4% | -425.7% | ||
| Q4 24 | -18.9% | 57.7% | ||
| Q3 24 | -2.4% | -925.0% | ||
| Q2 24 | -36.7% | -2503.2% | ||
| Q1 24 | -21.3% | — |
| Q4 25 | $0.71 | $-0.41 | ||
| Q3 25 | $-0.25 | $-0.52 | ||
| Q2 25 | — | $-0.46 | ||
| Q1 25 | $-0.27 | $-0.35 | ||
| Q4 24 | $-1.26 | $0.52 | ||
| Q3 24 | $-0.18 | $-0.20 | ||
| Q2 24 | — | $-0.13 | ||
| Q1 24 | $-1.44 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.5M | $245.0M |
| Total DebtLower is stronger | $233.2M | $96.4M |
| Stockholders' EquityBook value | $-85.2M | $114.3M |
| Total Assets | $101.1M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.5M | $245.0M | ||
| Q3 25 | $6.0M | $288.2M | ||
| Q2 25 | $6.1M | $240.1M | ||
| Q1 25 | $4.8M | $275.7M | ||
| Q4 24 | $15.4M | $314.0M | ||
| Q3 24 | $12.2M | $204.6M | ||
| Q2 24 | $11.6M | $218.7M | ||
| Q1 24 | $19.5M | $223.6M |
| Q4 25 | $233.2M | $96.4M | ||
| Q3 25 | $237.8M | $96.2M | ||
| Q2 25 | $240.5M | — | ||
| Q1 25 | $241.5M | — | ||
| Q4 24 | $227.2M | $0 | ||
| Q3 24 | $218.1M | — | ||
| Q2 24 | $225.7M | — | ||
| Q1 24 | $225.0M | — |
| Q4 25 | $-85.2M | $114.3M | ||
| Q3 25 | $-86.7M | $147.7M | ||
| Q2 25 | $-86.1M | $192.3M | ||
| Q1 25 | $-84.5M | $229.0M | ||
| Q4 24 | $-83.9M | $256.8M | ||
| Q3 24 | $-80.9M | $201.0M | ||
| Q2 24 | $-80.3M | $215.2M | ||
| Q1 24 | $-76.4M | $223.9M |
| Q4 25 | $101.1M | $327.7M | ||
| Q3 25 | $102.5M | $372.8M | ||
| Q2 25 | $104.1M | $313.5M | ||
| Q1 25 | $103.2M | $327.3M | ||
| Q4 24 | $110.6M | $351.2M | ||
| Q3 24 | $109.3M | $217.6M | ||
| Q2 24 | $107.8M | $222.0M | ||
| Q1 24 | $119.0M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-23.0K | $-43.5M |
| Free Cash FlowOCF − Capex | $-481.0K | — |
| FCF MarginFCF / Revenue | -2.8% | — |
| Capex IntensityCapex / Revenue | 2.6% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | $739.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-23.0K | $-43.5M | ||
| Q3 25 | $-296.0K | $-47.0M | ||
| Q2 25 | $5.9M | $-39.6M | ||
| Q1 25 | $-854.0K | $-40.7M | ||
| Q4 24 | $-781.0K | $42.0M | ||
| Q3 24 | $3.4M | $-14.5M | ||
| Q2 24 | $6.8M | $-7.3M | ||
| Q1 24 | $1.9M | $-6.7M |
| Q4 25 | $-481.0K | — | ||
| Q3 25 | $-1.3M | $-47.2M | ||
| Q2 25 | $3.6M | $-39.6M | ||
| Q1 25 | $-1.2M | $-40.8M | ||
| Q4 24 | $-1.1M | $41.7M | ||
| Q3 24 | $3.1M | $-14.6M | ||
| Q2 24 | $2.7M | $-7.3M | ||
| Q1 24 | $1.1M | $-6.8M |
| Q4 25 | -2.8% | — | ||
| Q3 25 | -7.1% | -145.4% | ||
| Q2 25 | 22.5% | -252.2% | ||
| Q1 25 | -6.8% | -512.1% | ||
| Q4 24 | -7.8% | 48.2% | ||
| Q3 24 | 18.3% | -706.3% | ||
| Q2 24 | 20.4% | -1463.4% | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 2.6% | 0.0% | ||
| Q3 25 | 5.4% | 0.6% | ||
| Q2 25 | 13.9% | 0.3% | ||
| Q1 25 | 1.8% | 1.1% | ||
| Q4 24 | 2.4% | 0.3% | ||
| Q3 24 | 1.6% | 6.8% | ||
| Q2 24 | 30.4% | 7.6% | ||
| Q1 24 | 4.9% | — |
| Q4 25 | -0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
